Promising new cocktail aims to tame multiple myeloma with fewer side effects
Disease control
Completed
This phase 2 trial tested a combination of three drugs—ixazomib, cyclophosphamide, and dexamethasone—as a first treatment for multiple myeloma. The goal was to see if this mix works better and causes fewer nerve problems than standard options. Twelve newly diagnosed patients took…
Phase: PHASE2 • Sponsor: John L. Reagan • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC